GSTM1 and neoplasm: ZIF-8 was used as a drug carrier for improving the Hb packaging rate, achieving pH-responsive Hb/O2 release, generating a large amount of O2 in the acidic TME, and relieving tumor hypoxia, thereby providing a source of O2 for US-triggered ROS generation.